RYAN ANNE PISHOCK: Open Payments
NPI 1972121390 · PLYMOUTH MEETING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,124 in 53 payments from 22 companies in 2025. Trend: 2023 $1,272 · 2024 $1,245 · 2025 $1,124
Food & beverage: $1,124
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $155 |
| Sumitomo Pharma America, Inc. | 6 | $144 |
| Novo Nordisk Inc | 5 | $90 |
| Lilly USA, LLC | 3 | $89 |
| ABBVIE INC. | 5 | $86 |
| Phathom Pharmaceuticals, Inc. | 5 | $81 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| SHIELD THERAPEUTICS INC | 1 | $48 |
| Verona Pharma, Inc. | 2 | $47 |
| Paratek Pharmaceuticals, Inc. | 2 | $41 |
Products named: GEMTESA, ELIQUIS, VOQUEZNA, JARDIANCE, TRELEGY ELLIPTA, VRAYLAR, ACCRUFER, Ohtuvayre.
Industry payments across PA — which companies pay providers there.
